G

Gushengtang Holdings Ltd
HKEX:2273

Watchlist Manager
Gushengtang Holdings Ltd
HKEX:2273
Watchlist
Price: 33.85 HKD -4.24% Market Closed
Market Cap: 8.1B HKD
Have any thoughts about
Gushengtang Holdings Ltd?
Write Note

Gushengtang Holdings Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Gushengtang Holdings Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
G
Gushengtang Holdings Ltd
HKEX:2273
Net Income (Common)
ÂĄ252.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
Net Income (Common)
ÂĄ161.2m
CAGR 3-Years
-58%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Topchoice Medical Co Inc
SSE:600763
Net Income (Common)
ÂĄ487m
CAGR 3-Years
-12%
CAGR 5-Years
1%
CAGR 10-Years
16%
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
Net Income (Common)
ÂĄ250.5m
CAGR 3-Years
-42%
CAGR 5-Years
-28%
CAGR 10-Years
6%
Dian Diagnostics Group Co Ltd
SZSE:300244
Net Income (Common)
-ÂĄ92.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
Net Income (Common)
ÂĄ279.7m
CAGR 3-Years
-33%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
No Stocks Found

Gushengtang Holdings Ltd
Glance View

Market Cap
8.3B HKD
Industry
Health Care

Gushengtang Holdings Ltd. operates the neo-TCM primary care platform, which combines inviting in-person care and seamless digital health powered by internet and AI technologies. The company is headquartered in Guangzhou, Guangdong. The company went IPO on 2021-12-10. The firm operates in two segments. Medical and Health Solutions segment is engaged in providing customers with traditional Chinese medical and health services through offline medical institutions and online medical and health platforms, including consultation, diagnosis, prescription services, decoctions and physical therapy. Sales of Medical and Health Products segment is mainly responsible for the sales of related products. The firm's main products include Ejiao, Cordyceps, cubilose, dendrobium, American Ginseng and other medicinal materials. The firm also provides honey, Ejiao cake and other nutritional products.

Intrinsic Value
74.36 HKD
Undervaluation 54%
Intrinsic Value
Price
G

See Also

What is Gushengtang Holdings Ltd's Net Income (Common)?
Net Income (Common)
252.2m CNY

Based on the financial report for Dec 31, 2023, Gushengtang Holdings Ltd's Net Income (Common) amounts to 252.2m CNY.

What is Gushengtang Holdings Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
39%

Over the last year, the Net Income (Common) growth was 39%.

Back to Top